269 related articles for article (PubMed ID: 12811711)
41. Intramuscular olanzapine for agitated patients: A systematic review and meta-analysis of randomized controlled trials.
Kishi T; Matsunaga S; Iwata N
J Psychiatr Res; 2015 Sep; 68():198-209. PubMed ID: 26228420
[TBL] [Abstract][Full Text] [Related]
42. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
43. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
Andrezina R; Josiassen RC; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; Iwamoto T
Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381
[TBL] [Abstract][Full Text] [Related]
44. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
Kinon BJ; Stauffer VL; Kollack-Walker S; Chen L; Sniadecki J
J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427
[TBL] [Abstract][Full Text] [Related]
45. Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.
Veser FH; Veser BD; McMullan JT; Zealberg J; Currier GW
J Psychiatr Pract; 2006 Mar; 12(2):103-8. PubMed ID: 16728906
[TBL] [Abstract][Full Text] [Related]
46. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
Tohen M; Goldberg JF; Gonzalez-Pinto Arrillaga AM; Azorin JM; Vieta E; Hardy-Bayle MC; Lawson WB; Emsley RA; Zhang F; Baker RW; Risser RC; Namjoshi MA; Evans AR; Breier A
Arch Gen Psychiatry; 2003 Dec; 60(12):1218-26. PubMed ID: 14662554
[TBL] [Abstract][Full Text] [Related]
47. The treatment of acute agitation in schizophrenia.
Battaglia J
CNS Spectr; 2007 Aug; 12(8 Suppl 11):4-5. PubMed ID: 17667892
[No Abstract] [Full Text] [Related]
48. Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department.
Klein LR; Driver BE; Miner JR; Martel ML; Hessel M; Collins JD; Horton GB; Fagerstrom E; Satpathy R; Cole JB
Ann Emerg Med; 2018 Oct; 72(4):374-385. PubMed ID: 29885904
[TBL] [Abstract][Full Text] [Related]
49. A prospective, observational study of the safety and effectiveness of intramuscular psychotropic treatment in acutely agitated patients with schizophrenia and bipolar mania.
Perrin E; Anand E; Dyachkova Y; Wagner T; Frediani S; Ballerini A;
Eur Psychiatry; 2012 May; 27(4):234-9. PubMed ID: 20620029
[TBL] [Abstract][Full Text] [Related]
50. Dosing the antipsychotic medication olanzapine.
Nemeroff CB
J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
[TBL] [Abstract][Full Text] [Related]
51. Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.
Marder SR; Sorsaburu S; Dunayevich E; Karagianis JL; Dawe IC; Falk DM; Dellva MA; Carlson JL; Cavazzoni PA; Baker RW
J Clin Psychiatry; 2010 Apr; 71(4):433-41. PubMed ID: 20156413
[TBL] [Abstract][Full Text] [Related]
52. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.
Isenberg DL; Jacobs D
Prehosp Disaster Med; 2015 Oct; 30(5):491-5. PubMed ID: 26323511
[TBL] [Abstract][Full Text] [Related]
53. Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses.
Tran PV; Dellva MA; Tollefson GD; Wentley AL; Beasley CM
Br J Psychiatry; 1998 Jun; 172():499-505. PubMed ID: 9828990
[TBL] [Abstract][Full Text] [Related]
54. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Powney MJ; Adams CE; Jones H
Cochrane Database Syst Rev; 2012 Nov; 11():CD009377. PubMed ID: 23152276
[TBL] [Abstract][Full Text] [Related]
55. The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations.
Crawford AM; Beasley CM; Tollefson GD
Schizophr Res; 1997 Jul; 26(1):41-54. PubMed ID: 9376336
[TBL] [Abstract][Full Text] [Related]
56. Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine.
Raveendran NS; Tharyan P; Alexander J; Adams CE;
BMJ; 2007 Oct; 335(7625):865. PubMed ID: 17954514
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study.
Lin J; Figuerado Y; Montgomery A; Lee J; Cannis M; Norton VC; Calvo R; Sikand H
Am J Emerg Med; 2021 Jun; 44():306-311. PubMed ID: 32340820
[TBL] [Abstract][Full Text] [Related]
58. The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis.
Bak M; Weltens I; Bervoets C; De Fruyt J; Samochowiec J; Fiorillo A; Sampogna G; Bienkowski P; Preuss WU; Misiak B; Frydecka D; Samochowiec A; Bak E; Drukker M; Dom G
Eur Psychiatry; 2019 Apr; 57():78-100. PubMed ID: 30721802
[TBL] [Abstract][Full Text] [Related]
59. Olanzapine for injection: new formulation. No advantage in agitated patients.
Prescrire Int; 2004 Jun; 13(71):92-3. PubMed ID: 15233144
[TBL] [Abstract][Full Text] [Related]
60. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
Tohen M; Ketter TA; Zarate CA; Suppes T; Frye M; Altshuler L; Zajecka J; Schuh LM; Risser RC; Brown E; Baker RW
Am J Psychiatry; 2003 Jul; 160(7):1263-71. PubMed ID: 12832240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
